Objectives: To assess extent of electronic cigarette use by smokers attending Stop Smoking Services, the advice given about electronic cigarettes and whether this usage is recorded.
Introduction
The number of countries around the world offering some form of Stop Smoking Service to smokers who wish to quit is accumulating steadily, although these often differ extensively in structure and outreach [1] . Perhaps one of the most comprehensive is the United Kingdom Stop Smoking Services established in 1999, which have been instrumental in reducing smoking rates [2] and have served as a model for other countries. These services are under the direction of local authorities, with each configuring itself on the basis of national guidelines.
The services aim to provide evidence-based behavioural support and access to smoking cessation medication [3, 4] .
With the release of the National Institute of Health and Care Excellence guidance on tobacco harm reduction in June 2013, the English Stop Smoking Services may be extended to offer support and guidance to smokers who are unable or unwilling to stop smoking [5] . The guidance covers two main forms of harm reduction -smoking reduction and temporary abstinence -which have both been shown to increase the propensity of smokers to stop, particularly if supported by licenced nicotine containing products [6] [7] [8] . Although this advice may take many forms, one recommendation is that guidance on harm reduction is incorporated into the brief advice given by health-care professionals prior to service attendance. This will reduce disruption to the current services and ensure the message is still that of complete abstinence [9] . However, smokers attempting harm reduction should be encourage to attend the services when they feel ready to quit smoking and given support to stop abruptly (Note:
although clinical trials have found that gradual cessation has similar efficacy as abrupt cessation, it appears to be less effective in the real world [see [10] [11] [12] ).
The National Institute of Clinical and Care Excellence guidance also acknowledged the potential contribution of electronic cigarettes (e-cigarettes) to tobacco harm reduction, but would only advocate this approach if they became licenced medicines in the UK. Studies have shown that these devices are becoming increasingly popular, and that they may help users to reduce or quit smoking [13] [14] [15] [16] [17] [18] [19] [20] . They also deliver clinically significant levels of nicotine into the blood, albeit, at least for some smokers, at a much lower level than traditional tobacco products [21] [22] [23] . Potentially harmful constituents have been identified in some cartridges [24, 25] ; though levels are much lower than those found in cigarettes [26] .
However, a major limitation with many of these studies is that they were based on surveys which recruited smokers from e-cigarette forums who are likely to hold more favourable attitudes towards such products. This is evident in the study by Dawkins et al [23] , where the authors reported that 74% of their sample had not smoked for several weeks since using ecigarettes. This far exceeds what would be expected for currently available efficacious treatments [27] . Much of the data thus far on safety and nicotine intake is also based on clinical trials, thus results may not play out in the real world where smokers will not generally be provided with e-cigarettes free of charge.
In June 2013, the Medicines and Healthcare products Regulatory Agency finalised their consultation on e-cigarettes and reached the decision that they should be regulated as medicines in the UK by 2016, in the belief that licensing would improve their safety and effectiveness [28] . This has put the UK at the forefront of the debate on e-cigarettes, with many other countries deliberating over their use or banning/imposing heavy restrictions, including Australia, Brazil, Lebanon, France, US and Singapore. Reasons for this hostility include the belief that they contain harmful substances, that they may encourage higher consumption of nicotine and that they will act as a gateway to smoking.
With the release of guidelines on harm reduction, and these regulatory changes to e-cigarettes, there is a need to determine the role that Stop Smoking Services will play. A first step, and the aim of this paper, is to ascertain the procedures stop smoking practitioners and managers have in place to record and advise smokers about the use of electronic cigarettes and to assess their beliefs about the prevalence and reasons for e-cigarette use among their clients.
It is important to discover whether Stop Smoking Services have provisions in place to record e-cigarette use, since careful monitoring will allow for the analysis of the impact of ecigarettes on quit rates over time and other significant clinical outcomes. It might be hypothesised that since they are not currently licensed, and therefore not available on prescription, that few if any monitoring procedures will be implemented. It is similarly important to determine the advice given by Stop Smoking Practitioners to ensure that the Stop Smoking Services are maintaining an evidence-based approach; since although there is strong endorsement for evidence-based practice in health-care fields, its use is often lacking [29] [30] [31] [32] .
One reason for this is that health-care professionals' personal beliefs often conflict with the evidence base and are more likely to influence practice [33] [34] [35] . For example, previous research shows that health-care professionals hold erroneous views about nicotine containing products and harm reduction generally, and that these beliefs are associated with the advice offered to smokers [36, 37] Finally, it is of interest to assess their beliefs about how many clients are using e-cigarettes and the reasons for their use, in order to inform future polices and the training offered to Stop Smoking Practitioners. Previous research suggests that smokers use e-cigarettes as they are less toxic than tobacco, to quit smoking or avoid relapsing, to deal with cravings for tobacco, during periods of temporary abstinence, for smoking reduction, and because they are cheaper than cigarettes [14, 15] . If a substantial proportion of e-cigarette users are attempting harm reduction then the prevalence of use in Stop Smoking Services may be low, on the basis that smokers who use nicotine containing products for harm reduction often do not approach health-care professionals and hold hostile beliefs about the services offered to smokers [38, 39] .
The specific questions addressed by the current study are as follows: 
Measures
The manager and practitioner survey comprised of 44 and 59 questions respectively. This paper reports on the subset of questions on e-cigarettes. These questions were developed by a group of researchers working in the area of tobacco harm reduction and e-cigarette use.
Question design was informed by prior research, with the intention being to keep questions as clear and concise as possible, and to provide response categorises which covered the most common answers but allowed open-ended responses [40] . Standard ethical guidelines were followed: participants could withdraw at any time, all data was anonymised and the burden of study participation minimized by keeping the questionnaire as brief as possible. Table 2 ). In line with the findings from the managers' survey, very few practitioners reported that systems were in place to record e-cigarette use. The main advice given was that ecigarettes were not yet approved/there was a lack of research to provide guidance (55.1%).
Discussion and conclusion

Discussion
The current study found that few Stop Smoking Services have systems in place to record ecigarette use, but that a large majority of service managers do provide practitioners with recommendations as to the advice they should give smokers about e-cigarettes. Common advice included that e-cigarettes are not currently approved or licensed and more research is required on their efficacy and safety. The actual advice that practitioners gave their clients was similar, except many also raised safety concerns. Surprisingly, the vast majority of practitioners reported that they had been asked questions about e-cigarettes and that their clients had tried or used them regularly. Use of e-cigarettes by clients for harm reduction was common. The advice being given to clients appeared to be largely evidence-based and followed the guidelines provided by service managers i.e. the majority of practitioners informed smokers that the products were not currently licensed for smoking cessation or harm reduction and that further research was required. However, a substantial proportion of practitioners also actively discouraged their use due to safety concerns. These concerns were generally along two lines:
It is perhaps unsurprising that few
1) stories that e-cigarettes could easily combust or explode and 2) that they contained compounds which were carcinogenic. These two points are not evidence-based. A recent study showed that the compounds in e-cigarettes are 9-450 times lower than the levels found in traditional cigarettes, and are comparable to the levels found in currently licensed nicotine containing products [26] and while it is the case that there are instances of e-cigarettes exploding, this occurs at a risk level similar to that for household goods.
Finally, it is perhaps surprising that so many practitioners have come across smokers who have tried or use e-cigarettes frequently, with a substantial minority reporting that nearly all their clients use e-cigarettes on a regular basis. These products as such appear to have high customer appeal, despite other nicotine containing products being available either at a lower price or for free depending on individual circumstance. One reason for this may be that smokers find traditional nicotine containing products unsatisfying [39] , since they are designed to minimize the risks of abuse and dependence [46] , or that this is simply a novelty effect. West, DiMarino and McNeill [47] reported an initial increase in use of the nicotine lozenge on its introduction to the UK market. However its use has since declined in favour of other products (e.g. the Nicotine patch) [6] . 
Practice implications
Despite a large majority of smokers attending Stop Smoking Services being interested in and/or are using e-cigarettes, nearly 1/3 rd of services do not provide practitioners with advice on what they should tell smokers. Mangers should be encouraged to keep up-to-date with developments in tobacco control and ensure that their services are providing consistent noncontradictory and accurate information. This can be achieved by providing practitioners with the necessary resources to undertake regular update training. Detailed information about ecigarettes should also be incorporated into training programmes for other health-care professionals who come into contact with smokers. In fact, it is likely that pharmacists and physicians will be the first point of call for many smokers using these products.
On the basis of current research, health-care professionals should be advised to inform smokers that some e-cigarettes are likely to be licensed by 2016 as medicinal smoking cessation aids; evidence suggests they are substantially safer than traditional cigarettes but further research is required to assess their effectiveness and safety profile; and that in the meantime they may wish instead to use currently licensed nicotine containing products, but the choice should be theirs.
The difficulty will be ensuring adherence to these guidelines given that previous studies have
shown that only 60% of the content of stop smoking manuals provided to practitioners is communicated with fidelity in practice [49] . Moreover, providing information to practitioners in countries which do not offer structured training is likely to be an arduous task [1] . [50] .
In addition to offering training to practitioners it should be recognized that factors other than knowledge and beliefs are important in ensuring that the guidelines and recommendations put forward by on e-cigarettes are implemented. Michie et al [33] identified a number of domains and related constructs which should be considered during the process of developing interventions to increase evidence-based practice. From this it could be argued that practitioners should not only receive training and information on the guidance, but should be encouraged to implement it, provided with an environment which is suitable for implementation, have access to the necessary tools, should receive prompts to remind them about the guidance, and reinforcement and praise for implementation. It should also be ensured that there is commitment from managerial levels and that any implementation does not conflict with current goals or create cognitive overload. Clearly this will be a difficult process in a climate of budget cuts, an ultimate goal to create a smoke-free society, and lack of time and resources. Thus it is important to consider carefully how and to what extent these guidelines are adopted by Stop Smoking Services.
Conclusion
A substantial number of smokers who attend Stop Smoking Services are now enquiring about e-cigarettes or report using them regularly for both smoking cessation and harm reduction. Managers. However, there is some variability in the advice given, with a substantial minority of practitioners actively discouraging smokers from using the devices due to unsubstantiated safety concerns.
